首页> 外文期刊>International Journal of Pharmaceutics >In vitro dissolution enhancement of micronized l-nimodipine by antisolvent re-crystallization from its crystal form H
【24h】

In vitro dissolution enhancement of micronized l-nimodipine by antisolvent re-crystallization from its crystal form H

机译:从H型晶体反溶剂重结晶可提高微粉化的L-尼莫地平的体外溶出度

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

In order to enhance solubility and dissolution rate in water, micronized l-nimodipine (NMD) has been successfully prepared by antisolvent re-crystallization process using acetone as solvent and deionized water as antisolvent. The effects of five experimental parameters on the mean particle size (MPS) of NMD nanosuspension were investigated. It was found that the MPS of NMD nanosuspension decreased significantly when the concentration of NMD-acetone solution increased from 50 to 150 mg/mL along with the increase of volume ratio of antisolvent to solvent from 1 to 3, and then increased slightly with the following increase of them. By contrast, the MPS decreased with the increased feed rate of NMD-acetone solution and the amount of surfactant, from 1 to 3 mL/min and 0.025% to 0.2%, respectively. Thereafter, the MPS did not show any obvious change. The precipitation temperature had no significant effects on MPS. The optimum micronization conditions were determined as follows: NMD-acetone solution concentration of 150 mg/mL, the volume ratio of antisolvent to solvent of 3, the flow rate of NMD-acetone solution of 9 mL/min, the preparation temperature of 15 C and the amount of the surfactant of 0.2%. Under optimum conditions, micronized NMD with a MPS of 708.3 nm was obtained. The micronized product was characterized using scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR), high performance liquid chromatography-mass spectrometry (LC-MS), X-ray diffraction (XRD), differential scanning calorimetry (DSC), and thermo gravimetric (TG), to verify the influences of micronization process on the final product. The results showed that the chemical structure of micronized NMD was not changed, but the crystalline structure had undergone transition during precipitation, which changed from form H into L. The dissolution test showed that micronized l-NMD exhibited enhanced dissolution rate and solubility of 5.22 folds compared to raw H-NMD. These results suggested that micronized l-NMD may have potential value to become a new oral NMD formulation with high bioavailability.
机译:为了提高在水中的溶解度和溶解速度,已经成功地通过以丙酮为溶剂,去离子水为反溶剂的反溶剂重结晶工艺制备了微粉化的l-尼莫地平(NMD)。研究了五个实验参数对NMD纳米悬浮液平均粒径(MPS)的影响。结果发现,当NMD-丙酮溶液的浓度从50 mg / mL增加到150 mg / mL,并且反溶剂与溶剂的体积比从1增加到3时,NMD纳米悬浮液的MPS显着降低,随后随以下条件而略有增加增加他们。相比之下,MPS随NMD-丙酮溶液的进料速率和表面活性剂含量的增加而降低,分别从1-3 mL / min和0.025%降至0.2%。此后,MPS没有显示任何明显的变化。沉淀温度对MPS没有显着影响。确定最佳的微粉化条件如下:NMD-丙酮溶液浓度为150 mg / mL,抗溶剂与溶剂的体积比为3,NMD-丙酮溶液的流速为9 mL / min,制备温度为15 C表面活性剂的量为0.2%。在最佳条件下,获得了MPS为708.3 nm的微粉化NMD。使用扫描电子显微镜(SEM),傅立叶变换红外光谱(FTIR),高效液相色谱-质谱(LC-MS),X射线衍射(XRD),差示扫描量热法(DSC)对微粉化产物进行表征热重法(TG),以验证微粉化工艺对最终产品的影响。结果表明,微粉化的NMD的化学结构没有改变,但在沉淀过程中发生了晶体结构的转变,从H型转变为L型。溶出度测试表明,L-NMD粉化后的溶出度和溶解度提高了5.22倍与原始H-NMD相比。这些结果表明,微粉化的1-NMD可能具有成为具有高生物利用度的新型口服NMD制剂的潜在价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号